Moreover, the viability of both HS-SY-II and SSH1 (a primary tumor cell derived from a patient with SS) cells increased progressively with increasing glutamine concentrations from 0 to 4 mM (Figure 2c,d). Here, SSH1 is linked to synovial sarcoma.